Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart

Cancer survival rates have increased significantly because of improvements in therapy regimes and novel immunomodulatory drugs. Recently, combination therapies of anthracyclines and immune checkpoint inhibitors (ICIs) have been proposed to maximize neoplastic cell removal. However, it has been specu...

Descripción completa

Detalles Bibliográficos
Autores principales: Korste, Sebastian, Settelmeier, Stephan, Michel, Lars, Odersky, Andrea, Stock, Pia, Reyes, Fabrice, Haj-Yehia, Elias, Anker, Markus S., Grüneboom, Anika, Hendgen-Cotta, Ulrike B., Rassaf, Tienush, Totzeck, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094326/
https://www.ncbi.nlm.nih.gov/pubmed/37047026
http://dx.doi.org/10.3390/ijms24076052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094326/
https://www.ncbi.nlm.nih.gov/pubmed/37047026
http://dx.doi.org/10.3390/ijms24076052

Ejemplares similares